Corticosteroid-related In-Hospital Hyperglycemia: Does It Negate Mortality Benefits in Coronavirus Disease 2019?
作者信息
Kow Chia Siang, Hasan Syed Shahzad
机构信息
School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
Department of Pharmacy, University of Huddersfield, Huddersfield, United Kingdom.
出版信息
Clin Infect Dis. 2021 Nov 2;73(9):e2848-e2849. doi: 10.1093/cid/ciaa1423.
Abstract
摘要
相似文献
1
Corticosteroid-related In-Hospital Hyperglycemia: Does It Negate Mortality Benefits in Coronavirus Disease 2019?
Clin Infect Dis. 2021 Nov 2;73(9):e2848-e2849. doi: 10.1093/cid/ciaa1423.
2
The association between corticosteroid uses and mortality among severe COVID-19 patients.
J Infect. 2021 Feb;82(2):e24. doi: 10.1016/j.jinf.2020.09.005. Epub 2020 Sep 12.
3
Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19.
Intensive Care Med. 2021 Mar;47(3):355-356. doi: 10.1007/s00134-020-06330-w. Epub 2021 Jan 2.
4
Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-2019.
J Comp Eff Res. 2020 Dec;9(18):1247-1254. doi: 10.2217/cer-2020-0146. Epub 2020 Nov 27.
5
Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.
Respirology. 2021 Aug;26(8):812-815. doi: 10.1111/resp.14108. Epub 2021 Jun 26.
6
Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).
Obstet Gynecol. 2021 Feb 1;137(2):379-380. doi: 10.1097/AOG.0000000000004271.
7
Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).
Obstet Gynecol. 2021 Feb 1;137(2):378-379. doi: 10.1097/AOG.0000000000004272.
8
The impact of inhaled corticosteroid on SARS-CoV2 infection.
J Allergy Clin Immunol Pract. 2021 Jul;9(7):2939-2940. doi: 10.1016/j.jaip.2021.04.039.
9
Corticosteroid Protection Against COVID-19: Begin with the Nose.
J Allergy Clin Immunol Pract. 2021 Nov;9(11):3941-3943. doi: 10.1016/j.jaip.2021.08.025. Epub 2021 Sep 17.
10
Response to: "Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort Study".
J Gerontol A Biol Sci Med Sci. 2023 Jun 1;78(6):1078-1079. doi: 10.1093/gerona/glad040.
引用本文的文献
1
Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials.
Inflammopharmacology. 2023 Oct;31(5):2773-2779. doi: 10.1007/s10787-023-01251-8. Epub 2023 Jun 2.
2
Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions.
Nat Rev Endocrinol. 2022 Sep;18(9):540-557. doi: 10.1038/s41574-022-00683-6. Epub 2022 May 18.
3
Pattern of medication utilization in hospitalized patients with COVID-19 in three District Headquarters Hospitals in the Punjab province of Pakistan.
Explor Res Clin Soc Pharm. 2022 Mar;5:100101. doi: 10.1016/j.rcsop.2021.100101. Epub 2021 Dec 29.
4
IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?
Cytokine. 2022 Jan;149:155730. doi: 10.1016/j.cyto.2021.155730. Epub 2021 Oct 5.
5
Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review.
J Clin Med. 2020 Dec 12;9(12):4021. doi: 10.3390/jcm9124021.
6
Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study.
Expert Rev Respir Med. 2021 Apr;15(4):543-552. doi: 10.1080/17476348.2021.1856659. Epub 2021 Feb 1.
Zotero 插件